cytarabine and transferrin

cytarabine has been researched along with transferrin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chitambar, CR; Zivkovic, Z1
Bianco, AR; Caraglia, M; Correale, P; Del Vecchio, S; Esposito, G; Genua, G; Pinto, A; Tagliaferri, P1
Byrd, JC; Chan, KK; Golan, S; Huynh, L; Jin, Y; Koh, CG; Lee, LJ; Lee, RJ; Liu, S; Marcucci, G; Muthusamy, N; Pang, J; Talmon, Y; Yang, J; Yang, X; Yu, B1

Other Studies

3 other study(ies) available for cytarabine and transferrin

ArticleYear
Inhibition of hemoglobin production by transferrin-gallium.
    Blood, 1987, Volume: 69, Issue:1

    Topics: Anemia, Hypochromic; Animals; Cell Division; Cell Line; Cytarabine; Dimethyl Sulfoxide; Erythropoiesis; Gallium; Hemoglobins; Iron; Isoniazid; Mice; Pyridoxal; Receptors, Transferrin; Transferrin

1987
Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb.
    Cancer immunology, immunotherapy : CII, 1993, Volume: 37, Issue:3

    Topics: Adenocarcinoma; Antibodies, Monoclonal; Cell Division; Cytarabine; Dose-Response Relationship, Drug; Epidermal Growth Factor; ErbB Receptors; Humans; Immunotherapy; Iodine Radioisotopes; KB Cells; Lung Neoplasms; Neoplasms; Radioimmunoassay; Receptors, Cell Surface; Receptors, Transferrin; Time Factors; Transferrin; Tumor Cells, Cultured; Up-Regulation

1993
Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemia.
    Molecular pharmaceutics, 2010, Feb-01, Volume: 7, Issue:1

    Topics: Antimetabolites, Antineoplastic; Base Sequence; Cell Line, Tumor; Cryoelectron Microscopy; Cytarabine; Down-Regulation; Drug Delivery Systems; Genetic Therapy; Humans; Hydrogen-Ion Concentration; K562 Cells; Leukemia, Myeloid, Acute; Nanoparticles; Oligodeoxyribonucleotides; Oligodeoxyribonucleotides, Antisense; Receptors, Transferrin; Ribonucleotide Reductases; RNA, Messenger; RNA, Neoplasm; Transferrin; Tumor Cells, Cultured

2010